Biogen Idec Hemophilia is categorized under Research and Development Laboratories in Cambridge, MA and active since 1997.
Biogen Idec Hemophilia was established in 1997, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Matt Otmer, President at the company’s single location by writing to 14 Cambridge Center, Cambridge, Massachusetts MA 02142 or by phoning (617) 914-5931. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biogen Idec Hemophilia |
| Contact Person: | Matt Otmer, President |
| Address: | 14 Cambridge Center, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 914-5931 |
| Website Address: | biogenidechemophilia.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 3254120 |
| Share This Business: |
Biogen Idec Hemophilia was started in 1997 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Matt Otmer, President for inquiries that concern Biogen Idec Hemophilia by calling the company number (617) 914-5931, as your correspondence is most welcome. Additionally, the physical location of the single location of Biogen Idec Hemophilia can be found at the coordinates 42.36575,-71.08688 as well as the street address 14 Cambridge Center in Cambridge, Massachusetts 02142.
For its online presence, you may visit Biogen Idec Hemophilia’s website at biogenidechemophilia.com and engage with its social media outlets through on Twitter and on Facebook.